AMD, an enzyme that catalyzes the conversion of terminal-glycine peptides to α-amidated peptides (Eipper et al., 1993), has been reported to be overexpressed in lung cancer cell lines, and AMD inhibitors can suppress the growth of cancer cells (Iwai et al., 1999; Vos et al., 1996). This evidence concerns the gene AMD1 and lung carcinoma.